NORMAL LEVELS OF ANTITHROMBIN III IN ACUTE LEUKEMIA COMPLICATED BY COAGULOPATHYVELLENGA E; MULDER NH.1980; ACTA HAEMATOL.; ISSN 0001-5792; CHE; DA. 1980; VOL. 63; NO 6; PP. 336-338; BIBL. 11 REF.Article

PLASMA BETA-THROMBOGLOBULIN IN NORMAL PREGNANCY AND PREGNANCY-INDUCED HYPERTENSIONDE VRIES JIP; VELLENGA E; AARNOUDSE JG et al.1983; EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY; ISSN 0301-2115; NLD; DA. 1983; VOL. 14; NO 4; PP. 209-216; BIBL. 1 P.Article

FAMILIAL THROMBOSIS IN A DUTCH FAMILY: INHERITED DEFICIENCY OF ANTITHROMBIN IIIVELLENGA E; MULDER NH; NIEWEG HO et al.1980; NETHERL. J. MED.; NLD; DA. 1980; VOL. 23; NO 4; PP. 149-151; BIBL. 17 REF.Article

RECURRENT INTESTINAL HAEMORRHAGES CAUSED BY A LIPOMA IN THE ILEOCAECAL VALVE IN A PATIENT WITH VON WILLEBRAND'S DISEASEHOEKSTRA HJ; WOBBES T; VELLENGA E et al.1980; NETH. J. SURG.; ISSN 0167-2487; NLD; DA. 1980; VOL. 32; NO 4; PP. 163-166; ABS. FRE/GER/DUTArticle

PLATELET ACTIVATION, FIBRINOLYTIC ACTIVITY AND CIRCULATING IMMUNE COMPLEXES IN RAYNAUD'S PHENOMENONKALLENBERG CGM; VELLENGA E; WOUDA AA et al.1982; JOURNAL OF RHEUMATOLOGY; ISSN 0315-162X; CAN; DA. 1982; VOL. 9; NO 6; PP. 878-884; BIBL. 34 REF.Article

Nanofiltration of combined salt and sugar solutions : coupling between retentionsVELLENGA, E; TRÄGARDH, G.Desalination (Amsterdam). 1998, Vol 120, Num 3, pp 211-220, issn 0011-9164Article

VASCULAR PROBLEMS IN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA: A REPORT OF TWO CASESVELLENGA E; MULDER NH; GIPS CH et al.1982; BLUT; ISSN 0006-5242; DEU; DA. 1982; VOL. 45; NO 4; PP. 261-265; BIBL. 20 REF.Article

ACUTE LYMPHOCYTIC LEUKAEMIA COMPLICATED BY HYPOFIBRINOGENAEMIA WITHOUT EVIDENCE FOR IMPAIRED FIBRINOGEN SYNTHESIS OR DISSEMINATED INTRAVASCULAR COAGULATIONVELLENGA E; VAN IMHOFF GW; STERRENBERG L et al.1983; ACTA HAEMATOLOGICA; ISSN 0001-5792; CHE; DA. 1983; VOL. 69; NO 6; PP. 419-421; BIBL. 3 REF.Article

The role of colony-stimulating factors in acute leukemiaHERRMANN, F; VELLENGA, E.Journal of cancer research and clinical oncology. 1990, Vol 116, Num 3, pp 275-282, issn 0171-5216, 8 p.Article

ENDOTOXIN IN PAROXYSMAL NOCTURNAL HAEMOGLOBULINURIA (PNH)VELLENGA E; MULDER NH; NIEWEG HO et al.1982; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1982; VOL. 50; NO 1; PP. 174-175; BIBL. 4 REF.Article

A FAMILIAL HEMORRHAGIC DIATHESIS IN A DUTCH FAMILY: AN INHERITED DEFICIENCY OF ALPHA 2-ANTIPLASMINKLUFT C; VELLENGA E; BROMMER EJP et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 59; NO 6; PP. 1169-1180; BIBL. 43 REF.Article

Effects of overexpression of the SH2-containing inositol phosphatase SHIP on proliferation and apoptosis of erythroid AS-E2 cellsBOER, A.-K; DRAYER, A. L; VELLENGA, E et al.Leukemia. 2001, Vol 15, Num 11, pp 1750-1757, issn 0887-6924Article

Myelodysplasia and apoptosis : new insights into ineffective erythropoiesisDE LOOSDRECHT, A. A. V; VELLENGA, E.Medical oncology (Northwood). 2000, Vol 17, Num 1, pp 16-21, issn 1357-0560Article

LYMPHOCYTE CHARACTERISTICS AND FUNCTION IN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIAVELLENGA E; ENSING GJ; HALIE MR et al.1983; BLUT; ISSN 0006-5242; DEU; DA. 1983; VOL. 47; NO 2; PP. 77-83; BIBL. 21 REF.Article

Interleukin-4 and its receptor ; modulating effects on immature and mature hematopoietic cellsVELLENGA, E; DOKTER, W; HALIE, R. M et al.Leukemia. 1993, Vol 7, Num 8, pp 1131-1141, issn 0887-6924Article

Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantationVELLENGA, E; SIZOO, W; HAGENBEEK, A et al.British journal of haematology. 1987, Vol 65, Num 2, pp 137-142, issn 0007-1048Article

The application of hematopoietic growth factors in drug-induced agranulocytosis : a review of 70 casesSPIKKELMAN, A; DE WOLF, J. T. M; VELLENGA, E et al.Leukemia. 1994, Vol 8, Num 12, pp 2031-2036, issn 0887-6924Article

Abnormal platelet adhesion on abdominal vessels in asymptomatic patients with paroxysmal nocturnal hemoglobinuriaLOUWES, H; VELLENGA, E; DE WOLF, J. T. M et al.Annals of hematology (Print). 2001, Vol 80, Num 10, pp 573-576, issn 0939-5555Article

Successful immunosuppressive treatment after failure of erythropoietin therapy in two subjects with refractory anaemiaMULLER, E. W; DE WOLF, J. T; VELLENGA, E et al.British journal of haematology. 1993, Vol 83, Num 1, pp 171-172, issn 0007-1048Article

Vascular proliferation as an unusual cause of hemorrhagic diathesis in myelofibrosisALBEDA, F. W; VAN DER MEER, J; VELLENGA, E et al.American journal of clinical pathology. 1991, Vol 95, Num 4, pp 564-566, issn 0002-9173Article

Therapeutic options in systemic AL amyloidosisVAN GAMEREN, I. I; LOKHORST, H; HAZENBERG, B. P. C et al.Netherlands journal of medicine. 2004, Vol 62, Num 4, pp 106-113, issn 0300-2977, 8 p.Article

Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in De novo and relapsed acute myeloid leukemiaVAN DER KOLK, D. M; DE VRIES, Ege; NOORDHOEK, L et al.Leukemia. 2001, Vol 15, Num 10, pp 1544-1553, issn 0887-6924Article

P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemiaVAN DER KOLK, D. M; DE VRIES, E. G. E; VAN PUTTEN, W. L. J et al.Clinical cancer research. 2000, Vol 6, Num 8, pp 3205-3214, issn 1078-0432Article

A dual function for p38 MAP kinase in hematopoietic cells : involvement in apoptosis and cell activationBIRKENKAMP, K. U; DOKTER, W. H. A; ESSELINK, M. T et al.Leukemia. 1999, Vol 13, Num 7, pp 1037-1045, issn 0887-6924Article

The influence of the membrane zeta potential on the critical flux for crossflow microfiltration of particle suspensionsHUISMAN, I. H; VELLENGA, E; TRÄGARDH, G et al.Journal of membrane science. 1999, Vol 156, Num 1, pp 153-158, issn 0376-7388Article